A Review Of Triazolam
nirmatrelvir will increase the amount or impact of triazolam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
Keep away from concomitant use of tucatinib with CYP3A substrates, in which small focus changes could lead to significant or lifetime-threatening toxicities. If